261 related articles for article (PubMed ID: 7583053)
1. Myofibroblasts and the progression of experimental glomerulonephritis.
Zhang G; Moorhead PJ; el Nahas AM
Exp Nephrol; 1995; 3(5):308-18. PubMed ID: 7583053
[TBL] [Abstract][Full Text] [Related]
2. Role of the extracellular matrix in the development of glomerulosclerosis in experimental chronic serum sickness.
Bergijk EC; Baelde HJ; de Heer E; Killen PD; Bruijn JA
Exp Nephrol; 1995; 3(6):338-47. PubMed ID: 8528678
[TBL] [Abstract][Full Text] [Related]
3. Myofibroblast phenotypes expression in experimental renal scarring.
Muchaneta-Kubara EC; el Nahas AM
Nephrol Dial Transplant; 1997 May; 12(5):904-15. PubMed ID: 9175042
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
5. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
Goumenos DS; Brown CB; Shortland J; el Nahas AM
Nephrol Dial Transplant; 1994; 9(10):1418-25. PubMed ID: 7816254
[TBL] [Abstract][Full Text] [Related]
6. Role of connective tissue growth factor in experimental radiation nephropathy in rats.
Liu DG; Wang TM
Chin Med J (Engl); 2008 Oct; 121(19):1925-31. PubMed ID: 19080126
[TBL] [Abstract][Full Text] [Related]
7. The effect of L-arginine on the progression of chronic renal scarring in remnant kidney.
Liu B; Haylor J; El Nahas AM
Chin Med J (Engl); 2002 Feb; 115(2):197-201. PubMed ID: 11940330
[TBL] [Abstract][Full Text] [Related]
8. [The role of smooth muscle alpha-actin in development of renal fibrosis in patients with chronic glomerulonephritis].
Chebotareva NV; Bobkova IN; Varshavskiĭ VA; Golitsyna EP; Kozlovskaia LV
Ter Arkh; 2006; 78(5):17-21. PubMed ID: 16889044
[TBL] [Abstract][Full Text] [Related]
9. Participation of the matrix metalloproteinase inhibitor in Thy-1 nephritis.
Mitani O; Katoh M; Shigematsu H
Pathol Int; 2004 Apr; 54(4):241-50. PubMed ID: 15028025
[TBL] [Abstract][Full Text] [Related]
10. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
[TBL] [Abstract][Full Text] [Related]
11. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
Liu D; Nazneen A; Taguchi T; Razzaque MS
Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
[TBL] [Abstract][Full Text] [Related]
12. Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix.
Vleming LJ; Baelde JJ; Westendorp RG; Daha MR; van Es LA; Bruijn JA
Clin Nephrol; 1995 Oct; 44(4):211-9. PubMed ID: 8575119
[TBL] [Abstract][Full Text] [Related]
13. Myofibroblasts in experimental hydronephrosis.
Diamond JR; van Goor H; Ding G; Engelmyer E
Am J Pathol; 1995 Jan; 146(1):121-9. PubMed ID: 7856721
[TBL] [Abstract][Full Text] [Related]
14. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy.
Ranieri E; Gesualdo L; Grandaliano G; Maiorano E; Schena FP
J Nephrol; 2001; 14(4):253-62. PubMed ID: 11506247
[TBL] [Abstract][Full Text] [Related]
15. Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney.
Boukhalfa G; Desmoulière A; Rondeau E; Gabbiani G; Sraer JD
Exp Nephrol; 1996; 4(4):241-7. PubMed ID: 8864727
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
[TBL] [Abstract][Full Text] [Related]
17. Myofibroblasts and the progression of crescentic glomerulonephritis.
Goumenos D; Tsomi K; Iatrou C; Oldroyd S; Sungur A; Papaioannides D; Moustakas G; Ziroyannis P; Mountokalakis T; El Nahas AM
Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
[TBL] [Abstract][Full Text] [Related]
18. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
[TBL] [Abstract][Full Text] [Related]
19. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease.
Wiggins R; Goyal M; Merritt S; Killen PD
Lab Invest; 1993 May; 68(5):557-65. PubMed ID: 8497127
[TBL] [Abstract][Full Text] [Related]
20. Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis.
Oba S; Kimura K; Suzuki N; Mise N; Tojo A; Miyashita K; Konno Y; Hirata Y; Goto A; Omata M
Am J Kidney Dis; 1998 Sep; 32(3):419-25. PubMed ID: 9740158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
